MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30.

Income Overview

Net Income
-$11,227K
EPS
-$1.53
Unit: Thousand (K) dollars

Income Statement
2025-09-30
2025-06-30
2024-12-31
2024-09-30
Research and development
6,914 9,583 18,119* 16,242
General and administrative
4,801 5,016 6,275* 5,706
Restructuring and impairment charges
0 0 368* -
Total operating expenses
11,715 14,599 24,761 21,948
Loss from operations
-11,715 -14,599 -24,761* -21,948
Interest income
1,026 1,197 2,348* 2,038
Interest expense
-302 384* 403
Other expenses
538 ---
Net loss
-11,227 -13,704 -22,797 -20,313
Basic EPS
-1.53 -1.87 -3.13 -2.78
Diluted EPS
-1.53 -1.87 -3.13 -2.78
Basic Average Shares
7,323,106 7,311,032 7,284,268 7,296,222
Diluted Average Shares
7,323,106 7,311,032 7,284,268 7,296,222
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$11,227K (44.73%↑ Y/Y)Interest income$1,026K (-49.66%↓ Y/Y)Loss from operations-$11,715K (46.62%↑ Y/Y)Other expenses$538K Total operatingexpenses$11,715K (-46.62%↓ Y/Y)Research and development$6,914K (-57.43%↓ Y/Y)General andadministrative$4,801K (-15.86%↓ Y/Y)

Kezar Life Sciences, Inc. (KZR)

Kezar Life Sciences, Inc. (KZR)